SEP 10, 2026 · JOURNAL ARTICLE
ROS-autocatalytic nanoplatform interfering astrocyte-cancer crosstalk and enhancing glioblastoma therapy
Nature Communications
Preclinical proof-of-concept study demonstrating a novel nanoplatform mechanism in cell and animal models, without human efficacy data or direct comparison to standard therapy.
Study details
DesignPreclinical mechanistic study (cell culture…
InterventionGS@DFP nanoplatform co-loaded with S-Gboxin…